Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propionyl-L-Carnitine with Exercise in PAD
NCT00399919Phase 3Completed
- Sponsor
- Leadiant Biosciences
- Start
- Apr 2006
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in peripheral artery disease (PAD) comparing PLC Arm with Placebo Arm (2 arms). Primary endpoint: Peak walking time at 6 months. Started Apr 2006; status: completed.
02
Drugs
propionyl-L-carnitine
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT00399919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399919.